The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI) and there was no benefit to the ...
MADRID — Taken together, two new randomized trials and a meta-analysis showed that beta-blockers following a myocardial infarction (MI) offer a relatively modest benefit in contemporary practice when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results